Diabetes Mellitus Impairs Blood-Brain Barrier Integrality and Microglial Reactivity

Area of Science:

• Neuroscience
• Endocrinology
• Immunology

Background:

• Diabetes mellitus (DM) is a chronic metabolic disorder impacting the central nervous system (CNS).
• Diabetes adversely affects the blood-brain barrier (BBB) and microglial function, potentially leading to neurodegeneration.
• The precise molecular links between diabetes, BBB dysfunction, and microglial dysregulation are not fully understood.

Purpose of the Study:

• To investigate the effects of diabetes on BBB integrity and microglial reactivity.
• To elucidate the molecular mechanisms connecting diabetes-induced BBB disruption and impaired microglial function.

Main Methods:

• Assessment of BBB integrity in a diabetes model.
• Evaluation of microglial response to vascular injury under diabetic conditions.
• Analysis of microglial P2RY12 expression in relation to BBB permeability.

Main Results:

• Diabetes significantly disrupts BBB integrity and impairs microglial responses to vascular injury.
• Increased BBB permeability correlates with downregulated microglial P2RY12 expression.
• Impaired microglial P2RY12 expression reduces their protective capacity against cerebrovascular injury in diabetes.

Conclusions:

• Diabetes severely compromises BBB integrity and microglial protective functions in the CNS.
• BBB disruption in diabetes leads to reduced microglial P2RY12 expression, exacerbating neurological damage.
• Understanding these mechanisms is crucial for developing therapies for diabetes-related neurological complications.